Finance

Lists
BLLN:NASDAQ
BillionToOne Inc
$97.91
-0.75%
(-0.74) 1D
Aug 11, 12:50:04 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for BLLN...
Open
$97.64
High
$99.07
Low
$94.45
Mkt. cap
4.62B
Avg. vol.
781.34K
Volume
236.15K
P/E ratio
175.75
52-wk high
$150.44
52-wk low
$61.96
EPS
$0.56
Shares outstanding
42.64M
No. of employees
713
Open
$97.64
High
$99.07
Low
$94.45
Mkt. cap
4.62B
Avg. vol.
781.34K
Volume
236.15K
P/E ratio
175.75
52-wk high
$150.44
52-wk low
$61.96
EPS
$0.56
Shares outstanding
42.64M
No. of employees
713
News stories
From web sources and news partners
About BillionToOne Inc
CEO-
Employees713
Founded2016
HeadquartersMenlo Park, California, United States
SectorHealth care provider
Analyst ratings
Based on 7 analysts giving stock ratings to BLLN in the past 3 months
Strong buy
Buy
6
Hold
1
Sell
0
12-month forecast
Based on 7 Wall Street analysts offering 12 month price targets for BLLN in the last 3 months.
Highest
Current $97.91
$145.00 (+48.10%)
Average
$123.33 (+25.96%)
Lowest
$90.00 (-8.08%)
Analyst
Recommendation
Action
Price target
Projected
Date
Matt Larew
William Blair
Buy
Maintained
-
-
08/06/2026
Daniel Arias
Stifel Nicolaus
Buy
Maintained
$145.00
+48.1%
08/06/2026
Casey Woodring
J.P. Morgan
Buy
Reiterated
$130.00
+32.8%
08/06/2026
Brandon Couillard
Wells Fargo
Hold
Maintained
$90.00
-8.1%
08/06/2026
David Westenberg
Piper Sandler
Buy
Reiterated
$120.00
+22.6%
08/06/2026
Mark Massaro
BTIG
Buy
Reiterated
$130.00
+32.8%
08/06/2026
Subbu Nambi
Guggenheim
Buy
Maintained
$125.00
+27.7%
06/29/2026
Andrew Brackmann
William Blair
Buy
Maintained
-
-
05/07/2026
Last report
Aug 5, 2026
Fiscal period
Q2 2026
EPS / Est. (USD)
$0.36 / $0.09
+298.67%beat
Revenue / Est. (USD)
109.45M / 108.52M
+0.86%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
83.52M
96.05M
108.39M
109.45M
Cost of goods sold
25.11M
27.45M
29.29M
32.34M
Cost of revenue
25.11M
27.45M
29.29M
32.34M
Research and development expenses
12.95M
14.25M
14.69M
17.32M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
35.83M
44.02M
46.57M
54.29M
Operating expense
48.78M
58.27M
61.26M
71.60M
Total operating expenses
73.89M
85.72M
90.55M
103.94M
Operating income
9.63M
10.33M
17.83M
5.50M
Other non operating income
-1.63M
-5.82M
301.00K
297.00K
EBT including unusual items
5.58M
6.30M
18.51M
7.52M
EBT excluding unusual items
9.52M
7.77M
22.77M
10.49M
Income tax expense
-129.00K
320.00K
539.00K
-536.00K
Effective tax rate
-2.31%
5.08%
2.91%
-7.13%
Other operating expenses
-
-
-
-
Net income
1.51M
2.53M
17.97M
8.05M
Net profit margin
1.80%
2.63%
16.58%
7.36%
Earnings per share
0.91
0.15
0.54
0.36
Interest and investment income
1.54M
3.26M
4.64M
4.69M
Interest expense
-20.00K
-3.00K
-10.00K
-8.00K
Net interest expenses
1.52M
3.26M
4.64M
4.69M
Depreciation and amortization charges
-
-
-
-
EBITDA
11.32M
12.01M
19.57M
7.33M
Gain or loss from assets sale
4.00K
48.00K
57.00K
7.00K
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
Google apps